Suppression of Lung Adenocarcinoma Progression by Nkx2-1

Despite the high prevalence and poor outcome of patients with metastatic lung cancer the mechanisms of tumour progression and metastasis remain largely uncharacterized. Here we modelled human lung adenocarcinoma, which frequently harbours activating point mutations in KRAS and inactivation of the p5...

Full description

Bibliographic Details
Main Authors: Winslow, Monte Meier (Contributor), Dayton, Talya Lucia (Contributor), Kim-Kiselak, Caroline (Contributor), Snyder, Eric (Contributor), Feldser, David M. (Contributor), DuPage, Michel J. (Contributor), Whittaker, Charles A. (Contributor), Hoersch, Sebastian (Contributor), Yoon, Stephanie M. (Contributor), Crowley, Denise G. (Contributor), Verhaak, Roel G. (Author), Hubbard, Diana D. (Author), Chiang, Derek Y. (Author), Myerson, Matthew (Author), Bronson, Roderick T. (Author), Jacks, Tyler E (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Jacks, Tyler E. (Contributor)
Format: Article
Language:English
Published: Nature Publishing Group, 2011-10-13T17:46:06Z.
Subjects:
Online Access:Get fulltext